https://www.neurologylive.com/view/neuroprotective-effects-aptoll-tlr4-receptor-angatonists-treat-ischemic-stroke
0
0
2/11/23 at 4:04pm
Organization
Neurologylive.com
Author
Marco Meglio
Investigators Macarena Hernandez, PhD, and Marc Ribo, MD, provided commentary on positive phase 2a findings assessing ApTOLL in combination with EVT in patients with ischemic stroke.
Create an account
or login to join the discussion